Errant Gene Therapeutics, LLC
San Rocco Therapeutics is dedicated to developing therapies for life-threatening rare diseases, rooted in a personal journey that began in 1992 when founder Patrick Girondi's son was diagnosed with Thalassemia. The enterprise evolved from pioneering gene therapy initiatives and collaborative clinical trials, focusing primarily on Sickle Cell Disease and Thalassemia, making significant strides in bringing affordable gene therapy to patients.
With a commitment to benevolence, mirroring the accomplishments of the patron saint it is named after, San Rocco has spearheaded numerous partnerships with prominent research institutions and hospitals worldwide. The company continues to pave the way for innovative treatments, driven by a deep dedication to improving the lives of those affected by these rare hematological conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.